The University of Chicago Header Logo

Connection

Richard Schilsky to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Lymphoma, Non-Hodgkin.
Richard Schilsky
Connection Strength
0.277
Lymphoma, Non-Hodgkin
  1. Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study. J Clin Oncol. 1995 Mar; 13(3):741-7.
    View in: PubMed
    Score: 0.109
  2. Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma. J Clin Oncol. 1987 Mar; 5(3):419-25.
    View in: PubMed
    Score: 0.063
  3. FDG-PET lymphoma demonstration project invitational workshop. Acad Radiol. 2007 Mar; 14(3):330-9.
    View in: PubMed
    Score: 0.063
  4. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150. Leuk Lymphoma. 2001 Nov-Dec; 42(6):1255-64.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.